These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35859599)

  • 21. Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes.
    Vandrey R; Herrmann ES; Mitchell JM; Bigelow GE; Flegel R; LoDico C; Cone EJ
    J Anal Toxicol; 2017 Mar; 41(2):83-99. PubMed ID: 28158482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults.
    Matheson J; Sproule B; Di Ciano P; Fares A; Le Foll B; Mann RE; Brands B
    Psychopharmacology (Berl); 2020 Feb; 237(2):305-316. PubMed ID: 31637452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects.
    Brands B; Mann RE; Wickens CM; Sproule B; Stoduto G; Sayer GS; Burston J; Pan JF; Matheson J; Stefan C; George TP; Huestis MA; Rehm J; Le Foll B
    Drug Alcohol Depend; 2019 Dec; 205():107641. PubMed ID: 31678833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
    Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
    J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.
    Desrosiers NA; Lee D; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
    Anal Bioanal Chem; 2014 Jan; 406(3):785-92. PubMed ID: 24292435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder.
    Brunette MF; Roth RM; Trask C; Khokhar JY; Ford JC; Park SH; Hickey SM; Zeffiro T; Xie H
    Schizophr Bull; 2024 Jun; ():. PubMed ID: 38900958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users.
    Maida N; Papaseit E; Martínez L; Pérez-Mañá C; Poyatos L; Pellegrini M; Pichini S; Pacifici R; Ventura M; Galindo L; Busardò FP; Farré M
    Biology (Basel); 2021 Mar; 10(4):. PubMed ID: 33805054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Examining impairment and kinetic patterns associated with recent use of hemp-derived Δ
    Wurz GT; Montoya E; DeGregorio MW
    J Cannabis Res; 2022 Jul; 4(1):36. PubMed ID: 35799289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC.
    Hunault CC; Mensinga TT; de Vries I; Kelholt-Dijkman HH; Hoek J; Kruidenier M; Leenders ME; Meulenbelt J
    Psychopharmacology (Berl); 2008 Dec; 201(2):171-81. PubMed ID: 18695931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
    PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetic modeling of plasma Δ9-tetrahydrocannabinol and an active and inactive metabolite following controlled smoked cannabis administration.
    Sempio C; Huestis MA; Mikulich-Gilbertson SK; Klawitter J; Christians U; Henthorn TK
    Br J Clin Pharmacol; 2020 Mar; 86(3):611-619. PubMed ID: 31747464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid concentrations in hair from documented cannabis users.
    Huestis MA; Gustafson RA; Moolchan ET; Barnes A; Bourland JA; Sweeney SA; Hayes EF; Carpenter PM; Smith ML
    Forensic Sci Int; 2007 Jul; 169(2-3):129-36. PubMed ID: 16963215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations.
    Huestis MA; Barnes A; Smith ML
    Clin Chem; 2005 Dec; 51(12):2289-95. PubMed ID: 16223887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation, but not microRNA expression, is affected by in vitro THC exposure in bovine granulosa cells.
    Floccari S; Sabry R; Choux L; Neal MS; Khokhar JY; Favetta LA
    BMC Pharmacol Toxicol; 2024 Jul; 25(1):42. PubMed ID: 39010179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).
    Hunault CC; Mensinga TT; Böcker KB; Schipper CM; Kruidenier M; Leenders ME; de Vries I; Meulenbelt J
    Psychopharmacology (Berl); 2009 May; 204(1):85-94. PubMed ID: 19099294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CB1 and CB2 receptor expression and promoter methylation in patients with cannabis dependence.
    Rotter A; Bayerlein K; Hansbauer M; Weiland J; Sperling W; Kornhuber J; Biermann T
    Eur Addict Res; 2013; 19(1):13-20. PubMed ID: 22948261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
    Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
    Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration.
    Newmeyer MN; Swortwood MJ; Taylor ME; Abulseoud OA; Woodward TH; Huestis MA
    J Appl Toxicol; 2017 Aug; 37(8):922-932. PubMed ID: 28138971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic and Pharmacodynamic Characterization of Tetrahydrocannabinol-Induced Cannabinoid Dependence After Chronic Passive Cannabis Smoke Exposure in Rats.
    Ravula A; Chandasana H; Jagnarine D; Wall SC; Setlow B; Febo M; Bruijnzeel AW; Derendorf H
    Cannabis Cannabinoid Res; 2019; 4(4):240-254. PubMed ID: 32042924
    [No Abstract]   [Full Text] [Related]  

  • 40. THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis".
    Pacifici R; Pichini S; Pellegrini M; Rotolo MC; Giorgetti R; Tagliabracci A; Busardò FP; Huestis MA
    Clin Chem Lab Med; 2020 Apr; 58(5):682-689. PubMed ID: 30956228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.